| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Idexx Laboratories Inc /de (IDXX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. IDXX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 82.4K | $44.99M | - | |
| VP | 13.7K | $7.46M | - | |
| VP | 10.4K | $5.69M | - | |
| VP | 6.3K | $3.46M | - | |
| VP | 1.6K | $875.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | Vandebroek Sophie V. | Director | Sale+OE | 1,279 | $491.34 | $628,425.27 | -52.3% | +32.2% | - | |
| Feb 10, 2025 | Fennell George | Executive Vice President | Sale+OE | 9,986 | $462.53 | $4,618,861.53 | -55.0% | +9.6% | +39.1% | |
| Feb 7, 2025 | Szostak M Anne | Director | Sell | 3,000 | $465.95 | $1,397,835.00 | -49.5% | +6.6% | +40.2% | |
| Nov 27, 2024 | Vandebroek Sophie V. | Director | Sell | 344 | $420.44 | $144,629.64 | -27.5% | +9.0% | +78.5% | |
| Sep 6, 2024 | Szostak M Anne | Director | Sell | 500 | $469.37 | $234,686.15 | -100% | -9.5% | +36.1% | |
| May 17, 2024 | Claflin Bruce L. | Director | Sell | 200 | $540.80 | $108,160.00 | -55.4% | -10.7% | -4.7% | |
| Mar 6, 2024 | Polewaczyk James F66 | Executive Vice President | Sale+OE | 8,104 | $558.44 | $4,525,596.16 | -18.1% | -11.9% | -23.0% | |
| Mar 5, 2024 | Vandebroek Sophie V. | Director | Sale+OE | 1,404 | $562.98 | $790,427.01 | -53.6% | -11.8% | -21.7% | |
| Feb 8, 2024 | Fennell George | SVP, Chief Revenue Officer | Sale+OE | 8,198 | $573.87 | $4,704,558.69 | -14.3% | -15.1% | -19.8% | |
| Feb 7, 2024 | McKeon Brian P69 | EVP, CFO And Treasurer | Sale+OE | 23,326 | $570.01 | $13,295,974.99 | -5.6% | -15.5% | -19.5% |